NASDAQ: AMGNAmgen Inc Stock Ownership - Who owns Amgen?
Insider buying vs selling
Have Amgen Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Jonathan P. Graham | EVP Gen. Counsel Secy. | 2025-03-17 | 3,150 | $313.71 | $988.19kSell |
| Esteban Santos | EVP Operations | 2025-03-17 | 3,393 | $313.71 | $1.06MSell |
| Robert A. Bradway | Chairman CEO and President | 2025-03-17 | 12,853 | $313.71 | $4.03MSell |
| David M. Reese | EVP Chief Technology Officer | 2025-03-17 | 3,635 | $313.71 | $1.14MSell |
| Peter H. Griffith | EVP CFO | 2025-03-17 | 3,305 | $313.71 | $1.04MSell |
| Matthew C. Busch | VP Finance CAO | 2025-03-17 | 174 | $313.71 | $54.59kSell |
| Derek Miller | SVP Human Resources | 2025-03-17 | 930 | $313.71 | $291.75kSell |
| Nancy A. Grygiel | SVP CCO | 2025-03-17 | 524 | $313.71 | $164.38kSell |
| Murdo Gordon | EVP Global Commercial Ops | 2025-03-17 | 4,039 | $313.71 | $1.27MSell |
| Rachna Khosla | SVP Business Development | 2025-03-17 | 489 | $313.71 | $153.40kSell |
AMGN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when AMGN insiders and whales buy or sell their stock.
AMGN Shareholders
What type of owners hold Amgen Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Vanguard Group Inc | 9.81% | 52,721,795 | $14.62B | Institution |
| Blackrock Inc | 8.50% | 45,646,148 | $12.66B | Institution |
| State Street Corp | 5.48% | 29,434,414 | $8.16B | Institution |
| Morgan Stanley | 2.71% | 14,559,622 | $4.04B | Institution |
| Charles Schwab Investment Management Inc | 2.46% | 13,205,604 | $3.66B | Institution |
| Primecap Management Co | 2.42% | 13,002,125 | $3.61B | Institution |
| Geode Capital Management LLC | 2.32% | 12,475,032 | $3.46B | Institution |
| Capital International Investors | 2.27% | 12,212,065 | $3.39B | Institution |
| Wells Fargo Company | 1.33% | 7,134,605 | $1.98B | Institution |
| Capital World Investors | 1.21% | 6,495,710 | $1.80B | Institution |
AMGN vs General Drug Manufacturer Stocks
Amgen Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.